Evaluation of the Therapeutic Effect of Lycoramine on Alzheimer's Disease in Mouse Model.

CONCLUSION: Lycoramine shows therapeutic potential to halt and reverse cognitive decline at the late stages of disease progression, and holds great promise for the treatment of Alzheimer's disease.
PMID: 33200692 [PubMed - as supplied by publisher]

Source: Current Medicinal Chemistry - November 16, 2020 Category: Chemistry Authors: Kiris I, Basar MK, Sahin B, Gurel B, Coskun J, Mroczek T, Baykal AT Tags: Curr Med Chem Source Type: research